91˿Ƶ

News

The Scientist - Bioterrorist battles

Published: 1 January 2012

A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.

Even if all the human-flu and animal-Ebola results are great, there is still the lingering question about the basic tenet of Evolva’s approach: whether those results will translate into a preventive for Ebola in humans.

“Animals have a very different set of susceptibilities to different infections,” points out Jonathan Kimmelman, an associate professor of biomedical ethics at 91˿Ƶ in Montreal. “All the time, drugs work miracles in animals, and they flunk their test in humans.”

Back to top